翰思艾泰生物医药科技（武汉）股份有限公司（股票名称：翰思艾泰-B，股票代码：03378）于2026年5月7日发布公告，披露公司当日在香港联交所场内回购普通股1.66万股（占回购前已发行股本约0.012%），回购价格区间介乎每股31.08港元至31.70港元，总涉资约52.05万港元。
公告显示，回购完成后，公司已发行股本（不包括库藏股）变动为135,716,130股，库藏股份增至502,700股。公司已获股东于2026年2月12日通过购回授权，总可回购股份数为13,621,883股，截至目前合计回购502,700股，约占授权通过当日已发行股本总数的0.369%。
公司确认上述回购活动遵守香港联交所证券上市规则及相关法律规定。公告由董事长兼执行董事张发明签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.